IMC Chicago’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.08M Sell
63,600
-15,800
-20% -$1.44M ﹤0.01% 1960
2025
Q4
$10.3M Sell
79,400
-16,500
-17% -$2.26M ﹤0.01% 1199
2025
Q3
$10.3M Sell
95,900
-51,800
-35% -$5.64M ﹤0.01% 1129
2025
Q2
$13.6M Buy
147,700
+125,200
+556% +$9.83M 0.01% 871
2025
Q1
$1.99M Buy
22,500
+12,300
+121% +$1.07M ﹤0.01% 1803
2024
Q4
$784K Buy
+10,200
New +$712K ﹤0.01% 2507

Other funds holding WGS

IMC Chicago's WGS Position: Q1 2026 in Review

IMC Chicago opened a new position in GeneDx Holdings (WGS) in Q1 2026: 4,643 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #4594 among its holdings.

240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • IMC Chicago held 4,643 shares of GeneDx Holdings worth $298K as of Q1 2026.
  • GeneDx Holdings was a new IMC Chicago position in Q1 2026.
  • GeneDx Holdings made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4594 holding.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.